Failure of critical protein connection at heart of cardiomyopathy

HOUSTON--(March 16, 2002)--The failure of dystrophin, one of the building blocks that literally holds heart muscle cells together, can cause dilated cardiomyopathy (DCM), a condition in which the pumping chambers of the heart enlarge and cannot pump adequately, according to researchers at Baylor College of Medicine in a report in todays issue of the journal The Lancet.

However, allowing the heart to rest by using a mechanical device called a ventricular assist device or VAD allows dystrophin to resume its function and restores the heart to more normal pumping, said Dr. Jeffrey Towbin, professor of pediatrics and cardiology at Baylor and the senior author of the report.

Dystrophin is probably best known for its relationship to Duchenne and Becker muscular dystrophy, diseases in which the muscles weaken, the child requires a wheelchair and dilated cardiomyopathy occurs. A mutation in the dystrophin gene causes these diseases.

However, in the case of dilated cardiomyopathy alone, the end portion of the dystrophin protein loses a critical connection between the cells contractile apparatus and the cellular membrane. As a result, the heart cannot contract adequately, said Drs. Jeffrey Towbin and Neil Bowles, also a member of the Baylor research team.

Towbin and his colleagues took samples from 10 patients with ischemic (disease of the coronary artery) and 10 patients with non-ischemic dilated cardiomyopathies resulting from different causes who were awaiting heart transplants. Samples were also obtained from six patients with dilated cardiomyopathy who were being treated with these ventricular assist pumps. They compared the patient samples to normal samples taken from transplanted hearts and found the abnormality in the dystrophin of roughly 90 percent of all the patients with cardiomyopathy.

There are two theories about why the protein becomes disconnected. One is mechanical. As the heart pumps harder and harder over a number o

Contact: Lori Williams/Ron Gilmore
Baylor College of Medicine

Page: 1 2

Related biology news :

1. Failure of DNA repair mechanism precedes final stage of deadly leukemia, new Penn study shows
2. Failures in primate cloning may signal impossibility of human reproductive cloning
3. Immunex And Wyeth-Ayerst Laboratories Advance Enbrel Into Phase II/III Clinical Trial For Chronic Heart Failure
4. Duke Scientist Reports Advances In Gene Therapy For Heart Failure
5. Local Approaches To Combating Antibiotic Resistance Are Doomed To Failure
6. Circulatory Device -- A Bridge To Recovery For Heart Failure?
7. Molecular Key To Heart Failure Development
8. Gene-Altered Mice Boost Studies of Cardiomyopathy: Enables Research Into Causes And Treatment Of Heart Failure
9. Possible Trigger For Heart Failure Identified In Lab Animal Studies
10. UCSD team determines cellular stress within body is critical
11. Carnegie Mellon U biologists identify critical player in yeast ribosome assembly

Post Your Comments:

(Date:8/15/2017)... 2017   ivWatch LLC , a medical device company focused ... announced receipt of its ISO 13485 Certification, the global standard for ... for Standardization (ISO®). ... 400 Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 /PRNewswire/ ... leader in dairy research, today announced a new collaboration ... reduce the chances that the global milk supply is ... dairy project, Cornell University has become the newest academic ... Supply Chain, a food safety initiative that includes IBM ...
(Date:5/16/2017)... -- Veratad Technologies, LLC ( www.veratad.com ), an innovative and ... solutions, announced today they will participate as a sponsor ... May 17, 2017, in Washington D.C.,s ... Identity impacts the lives of billions of ... digital world, defining identity is critical to nearly every ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... 10, 2017 , ... For the second time in three ... Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. Tuesday, October ... US2020’s mission is to change the trajectory of STEM education in America by ...
Breaking Biology Technology:
Cached News: